Chemical Compound Review:
SureCN26181 cyclohexanecarboxamide
Synonyms:
CHEMBL366975, AG-D-31256, SureCN1714291, ACMC-20alcz, NSC-16584, ...
- Effect of IS-741 on cell adhesion between human umbilical vein endothelial cells and HL-60 cells. Shikama, H., Yotsuya, S., Satake, S., Sugi, H., Kato, M. Biol. Pharm. Bull. (1999)
- Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K. Crane, S.N., Black, W.C., Palmer, J.T., Davis, D.E., Setti, E., Robichaud, J., Paquet, J., Oballa, R.M., Bayly, C.I., McKay, D.J., Somoza, J.R., Chauret, N., Seto, C., Scheigetz, J., Wesolowski, G., Massé, F., Desmarais, S., Ouellet, M. J. Med. Chem. (2006)
- Nitric oxide relaxes circular smooth muscle of rat distal colon through RhoA/Rho-kinase independent Ca2+ desensitisation. Colpaert, E.E., Levent, A., Lefebvre, R.A. Br. J. Pharmacol. (2005)
- N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract. Leonardi, A., Guarneri, L., Poggesi, E., Angelico, P., Velasco, C., Cilia, A., Testa, R. J. Pharmacol. Exp. Ther. (2001)
- Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice. Büyükafşar, K., Yalçin, I., Kurt, A.H., Tiftik, R.N., Sahan-Firat, S., Aksu, F. Eur. J. Pharmacol. (2006)
- Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates. Alper, R.H., Nelson, D.L. Eur. J. Pharmacol. (2000)
- 5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus. Matos, F.F., Korpinen, C., Yocca, F.D. Eur. J. Pharmacol. (1996)
- Antagonism of the 5-HT1A receptor stimulus in a conditioned taste aversion procedure. Berendsen, H.H., Broekkamp, C.L. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. (1999)
- Effects of the Rho-kinase inhibitors, Y-27632 and fasudil, on the corpus cavernosum from diabetic mice. Büyükafşar, K., Un, I. Eur. J. Pharmacol. (2003)
- Discriminative stimulus properties of flesinoxan: effects of enantiomers, (S)-UH301 and WAY-100635. Gommans, J., Hijzen, T.H., Maes, R.A., Mos, J., Olivier, B. Eur. J. Pharmacol. (1995)
- Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes. Alper, R.H., Nelson, D.L. Eur. J. Pharmacol. (1998)
- Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET. Osman, S., Lundkvist, C., Pike, V.W., Halldin, C., McCarron, J.A., Swahn, C.G., Ginovart, N., Luthra, S.K., Bench, C.J., Grasby, P.M., Wikström, H., Barf, T., Cliffe, I.A., Fletcher, A., Farde, L. Nucl. Med. Biol. (1996)
- Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling. Osman, S., Lundkvist, C., Pike, V.W., Halldin, C., McCarron, J.A., Swahn, C.G., Farde, L., Ginovart, N., Luthra, S.K., Gunn, R.N., Bench, C.J., Sargent, P.A., Grasby, P.M. Nucl. Med. Biol. (1998)